Calithera Biosciences, Inc. financial reports, Calithera Biosciences, Inc. annual revenue in 2024. When does Calithera Biosciences, Inc. report revenue?
Calithera Biosciences, Inc. total revenue, net income and dynamics of changes in US dollar today
Calithera Biosciences, Inc. current income in US dollar. The dynamics of Calithera Biosciences, Inc. net revenue grew by 0 $ compared to the previous report. Calithera Biosciences, Inc. net income is now -20 395 000 $. Schedule of the financial report of Calithera Biosciences, Inc. for today. The financial schedule of Calithera Biosciences, Inc. consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. The value of Calithera Biosciences, Inc. assets on the online chart is displayed in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
0 $
-
-20 395 000 $
-
31/12/2020
0 $
-
-22 566 000 $
-
30/09/2020
0 $
-
-22 734 000 $
-
30/06/2020
0 $
-
-20 391 000 $
-
30/09/2019
0 $
-
-20 293 000 $
-
30/06/2019
0 $
-
-24 152 000 $
-
31/03/2019
0 $
-
-23 687 000 $
-
31/12/2018
0 $
-
-19 499 000 $
-
30/09/2018
0 $
-
-18 849 000 $
-
30/06/2018
17 065 000 $
-
-3 075 000 $
-
31/03/2018
5 189 000 $
-
-13 206 000 $
-
31/12/2017
7 254 000 $
-
-10 974 000 $
-
30/09/2017
7 254 000 $
-
-6 071 000 $
-
30/06/2017
7 255 000 $
-
-5 194 000 $
-
Show:
to
Calithera Biosciences, Inc. financial report charts
Dates of Calithera Biosciences, Inc. finance reports: 30/06/2017, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The latest financial report of Calithera Biosciences, Inc. is available online for such a date - 31/03/2021. Gross profit Calithera Biosciences, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Calithera Biosciences, Inc. is -14 439 000 $
Calithera Biosciences, Inc. quarterly report dates
Cost of revenue Calithera Biosciences, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Calithera Biosciences, Inc. is 14 439 000 $ Operating income Calithera Biosciences, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Calithera Biosciences, Inc. is -19 667 000 $ Net income Calithera Biosciences, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Calithera Biosciences, Inc. is -20 395 000 $
Current assets Calithera Biosciences, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Calithera Biosciences, Inc. is 106 509 000 $ Total assets Calithera Biosciences, Inc. refers to the total amount of assets owned by a person or entity. Total assets Calithera Biosciences, Inc. is 110 657 000 $ Current cash Calithera Biosciences, Inc. - the sum of all of the cash a company has on the date of report. Current cash Calithera Biosciences, Inc. is 101 351 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-14 439 000 $
-17 077 000 $
-18 157 000 $
-15 656 000 $
-17 221 000 $
-20 928 000 $
-20 239 000 $
-16 977 000 $
-16 420 000 $
-240 000 $
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
14 439 000 $
17 077 000 $
18 157 000 $
15 656 000 $
17 221 000 $
20 928 000 $
20 239 000 $
16 977 000 $
16 420 000 $
17 305 000 $
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
-
-
-
-
-
-
-
-
-
17 065 000 $
5 189 000 $
7 254 000 $
7 254 000 $
7 255 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
-
17 065 000 $
5 189 000 $
7 254 000 $
7 254 000 $
7 255 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-19 667 000 $
-22 663 000 $
-22 901 000 $
-20 752 000 $
-21 127 000 $
-24 912 000 $
-24 403 000 $
-20 224 000 $
-19 507 000 $
-3 738 000 $
-13 812 000 $
-11 542 000 $
-6 653 000 $
-5 735 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-20 395 000 $
-22 566 000 $
-22 734 000 $
-20 391 000 $
-20 293 000 $
-24 152 000 $
-23 687 000 $
-19 499 000 $
-18 849 000 $
-3 075 000 $
-13 206 000 $
-10 974 000 $
-6 071 000 $
-5 194 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
20 239 000 $
20 239 000 $
20 239 000 $
20 239 000 $
15 493 000 $
15 496 000 $
10 833 000 $
10 142 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
19 667 000 $
22 663 000 $
22 901 000 $
20 752 000 $
21 127 000 $
24 912 000 $
24 403 000 $
20 224 000 $
19 507 000 $
20 803 000 $
19 001 000 $
18 796 000 $
13 907 000 $
12 990 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
106 509 000 $
118 703 000 $
140 036 000 $
156 552 000 $
136 798 000 $
156 478 000 $
121 198 000 $
140 252 000 $
144 818 000 $
145 438 000 $
155 812 000 $
167 667 000 $
172 053 000 $
170 387 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
110 657 000 $
125 587 000 $
147 708 000 $
164 927 000 $
146 319 000 $
166 376 000 $
131 906 000 $
142 725 000 $
147 674 000 $
158 975 000 $
178 584 000 $
192 455 000 $
205 543 000 $
214 082 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
101 351 000 $
107 146 000 $
120 582 000 $
114 895 000 $
21 661 000 $
76 792 000 $
40 584 000 $
51 058 000 $
61 135 000 $
55 870 000 $
55 281 000 $
48 475 000 $
39 411 000 $
57 997 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
18 505 000 $
19 418 000 $
17 944 000 $
14 881 000 $
10 605 000 $
10 648 000 $
-
-
-
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
150 964 000 $
163 793 000 $
165 613 000 $
166 231 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
25 660 000 $
26 994 000 $
25 932 000 $
16 011 000 $
11 764 000 $
11 810 000 $
-
-
-
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
17.54 %
16.22 %
19.66 %
11.22 %
7.97 %
7.43 %
-
-
-
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
94 158 000 $
102 371 000 $
122 596 000 $
143 284 000 $
120 659 000 $
139 382 000 $
105 974 000 $
126 714 000 $
135 910 000 $
147 165 000 $
147 867 000 $
150 307 000 $
158 092 000 $
162 464 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-19 676 000 $
-20 050 000 $
-20 624 000 $
-13 888 000 $
-16 562 000 $
-19 440 000 $
-14 952 000 $
-11 363 000 $
-11 305 000 $
1 168 000 $
Last revenue report of Calithera Biosciences, Inc. was 31/03/2021. According to last financial report total revenue in Calithera Biosciences, Inc. was 0 US dollar and changed by 0% since last year. Net income in Calithera Biosciences, Inc. was -20 395 000 $ in last quartal, net income changes to 0%.
Calithera Biosciences, Inc. stocks data
CALA stock price
Calithera Biosciences, Inc. stock price today, CALA stock quote.
